The cost of treating hepatitis D infection in the United States reached nearly $600 million in 2015, according to a new study that found a startlingly high economic burden caused by the poorly understood illness.
Hepatitis D virus (HDV) often accompanies HBV infection, so the researchers, from Rutgers University and the Robert Wood Johnson Medical School, in New Jersey, used a commercial database to identify people with both viruses in 2015. They found 13,548 patients with HBV, of whom 780 had